Build advanced pharmaceutical and pharmaceutical production bases such as biological agents and pharmaceutical intermediates.
Construct a complete technical service system for pharmaceutical intermediates and pharmaceutical chemical innovation, industrial incubation.
Provide one-stop service from gene to production, effectively reducing partners’ early R&D investment and technology barrier.
Biomedicine, as well as a public service platform for pharmaceutical and chemical industries
R&D base meets GMP standards.
Investing more than 20 million US dollars in production base.
Biopharmaceutical expression, culture transformation, purification, sterile powder injection, research on pharmaceutical chemistry, steroids.
Sound GMP quality assurance system.